Biodesix Inc at Barclays Global Healthcare Conference Transcript
Good afternoon, everybody. I'm Luke Sergott. I cover life science tools and diagnostics here at Barclays. With me, it's my pleasure to have Robin Cowie, CFO of Biodesix. Thanks again for making it. And sorry for being a little bit late here. We have a little bit break so we can run over.
Questions & Answers
But I guess let's start off, relatively unfamiliar with the business of meeting you guys a couple of times and scaling up. So for those that aren't familiar with, with what you guys do, kind of walk us through just the one-on-one of where the technology, what the platform is and how you're building it and like where you guys are going.
Yeah, sure, absolutely. So Biodesix is a diagnostic company. We're dedicated to developing tests to help improve patient lives and outcomes focusing on specific clinical questions. Commercially, we're primarily focused in the area
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
